by Usha Govindarajulu | Feb 4, 2022 | Biostatistics, Blog, COVID-19, New York, Professor, Usha Govindarajulu
February 2, 2022 A recent article in the Lancet Infectious Diseases presents a large scale study of post-vaccination infection conducted in the United Kingdom to assess potential long-haul symptoms. It was a prospective, community-based, nested, case-control study...
by Usha Govindarajulu | Sep 30, 2021 | Biostatistics, Blog, Healtcare, New York, Professor, Usha Govindarajulu
Booster shots for all vaccines September 30, 2021 The Centers for Disease Control and Prevention (CDC) has been promoting booster shots most recently for all vaccines for COVID-19: Pfizer, Moderna, and Johnson & Johnson. However, the Food & Druge...
by Usha Govindarajulu | Mar 3, 2021 | Biostatistics, Blog, Epidemiology, New York, Professor, Usha Govindarajulu
As of right now, this is what we know about serious safety concerns raised about these COVID-19 vaccines: the mRNA vaccines, Pfizer© and Moderna©, the Johnson & Johnson©vaccine, and the Oxford/Astrazeneca© vaccine. These are the current vaccines with...
by Usha Govindarajulu | Feb 17, 2021 | Blog, Epidemiology, Healtcare, New York, Professor, Usha Govindarajulu
Much of the new these days focuses around the vaccines that are out on the market due to emergency authorizations for their use due the continued spread and decimation caused by COVID-19. One of the major concerns that have been raised besides safety are also how the...
by Usha Govindarajulu | Feb 3, 2021 | Biostatistics, Blog, Epidemiology, New York, Professor, Usha Govindarajulu
Recently, two more vaccines are being reviewed in the news for their efficacy and usefulness in the fight against COVID-19. The producers are Johnson & Johnson and Novavax. The Johnson & Johnson or J&J has been discussed earlier than the other since it...
by Usha Govindarajulu | Jan 20, 2021 | Biostatistics, Blog, Epidemiology, New York, Professor, Usha Govindarajulu
As we continue to hear news of COVID-19 variants making their landfall and presence in the United States, the mass vaccination campaign continues. Meanwhile as cases continue to surge, hospitals are overflowing, and deaths have reached almost 400,000, vaccinations...